BO 1341

• Description:

  BO 1341 is a PBPs inhibitor and an antipseudomonal semisynthetic cephalosporin, which belongs to the class of Antibiotic. BO 1341 exhibits antibacterial activity against most Gram-negative bacteria, such as Pseudomonas aeruginosa (MIC90: 1.56 μg/mL), Pseudomonas maltophilia (MIC50: 1.56 μg/mL), and Acinetobacter calcoaceticus (MIC90: 3.13 μg/mL) . BO 1341 can be used in the research of infectious diseases[1].

• UNSPSC:

  12352005

• Target:

  Antibiotic; Bacterial

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Smiles:

  [O-]C(C1=C(C[N+]2=CC3=CC(O)=C(O)C=C3C=C2)CS[C@@]([C@@H]4NC(/C(C5=CSC(N)=N5)=N/OC(C)(C)C(O)=O)=O)([H])N1C4=O)=O

• Molecular Formula:

  C26H24N6O9S2

• Molecular Weight:

  628.63

• References & Citations:

  [1]Nakagawa S, et al. In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin. Antimicrob Agents Chemother. 1989 Sep;33 (9) :1423-7.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [119068-46-1]